Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
For full access to this article login to GEN Select now.
3-D Cell Culture for Discovery & Bioprocess
Approach Gaining in Popularity Due to Its Ability to Mimic an In Vivo Growth Environment
- Two key issues for the pharmaceutical industry include accuracy of predicting in vivo drug interactions, including toxicity, and the time/cost of drug development. According to a 2007 report in Archives of Internal Medicine , the number of serious adverse and fatal drug events in the U.S., as reported to ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.